Clinical Trial

A Phase II Clinical Trial of the Safety and Efficacy of SAL0120 in Patients With Chronic Kidney Disease (CKD)

Name: A Phase II Clinical Trial of the Safety and Efficacy of SAL0120 in Patients With Chronic Kidney Disease (CKD) — clinical trial record (NCT07716618)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Active, Not Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

This study is a multicenter, randomized, double-blind, placebo-controlled, parallel-design clinical trial designed to investigate the efficacy and safety of different doses of sal0120 tablets in patients with CKD.

Trial Details

NCT Number	NCT07716618
Lead Sponsor	Shenzhen Salubris Pharmaceuticals Co., Ltd. Collaborators: Salubris (Suzhou) Pharmaceutical Co., Ltd.
Conditions	Chronic Kidney Disease
Enrollment	320 participants
Start Date	2025-01-17
Primary Completion	2026-05-27 (estimated)
Study Completion	2026-08-31 (estimated)
Updated on ClinicalTrials.gov	2026-07-21